Neudle.com: Alzheimer s disease screening

Differential
(Click to cross reference)

abiotrophy

abscess, intracerebral

abscess, intracranial-fungal

acetylcholine receptor

acetylcholinesterase

acetyl-L-carnitine

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome, older adults

activated protein C resistance

activities of daily living

activities of daily living scale

addiction, heroin

aducanumab

advance directives

advances in neurology

adverse drug reaction

aerobic exercise

age associated memory impairment

alcohol, neurologic complications with

Alzheimer type II astrocytosis

Alzheimer's disease

Alzheimer's disease associated protein

Alzheimer's disease, age of onset

Alzheimer's disease, behavioral symptoms

Alzheimer's disease, conjugal

Alzheimer's disease, diagnosis of

Alzheimer's disease, driving with

Alzheimer's disease, early onset

Alzheimer's disease, early symptoms

Alzheimer's disease, familial

Alzheimer's disease, familial, late onset

Alzheimer's disease, heterogeneity of

Alzheimer's disease, incidence

Alzheimer's disease, misdiagnosis

Alzheimer's disease, noncognitive symptoms

Alzheimer's disease, pathogenesis

Alzheimer's disease, patient awareness of

Alzheimer's disease, preclinical

Alzheimer's disease, prognosis of

Alzheimer's disease, rapidly progressive

Alzheimer's disease, rate of clinical decline

Alzheimer's disease, risk factors in

Alzheimer's disease, staging

Alzheimer's disease, telling patient diagnosis of

Alzheimer's disease, treating associated medical problems in

Alzheimer's disease, treatment of

Alzheimer's disease, vaccine

Alzheimer's disease, visual variant

amyloid angiopathy, cerebral

amyloid beta protein

amyloid beta protein antibodies

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, epidemiology of

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, guamian type of

anatomy of

aneuploidy

aneurysm, intracranial, familial

angiitis, isolated of CNS

angiotensin II receptor blocker

anticardiolipin antibodies

anticholinergic drugs

anticholinesterase

anticoagulant, treatment

antiphospholipid antibodies

antithrombin III deficiency

aphasia, classification of

aphasia, logopenic, progressive

aphasia, progressive

aphasia, progressive, non-fluent

aphasia, progressive, primary

aphasia, transcortical

aphasia, transcortical-sensory

apolipoprotein E

apolipoprotein E, false positive

apoliprotein E, plasma level

apraxia, constructional

arterial dissection

arterial dissection, carotid

arthrogryposis multiplex

autonomic dysfunction

bacterial infection

Balint's syndrome

basal ganglia, lesion of

basilar artery migraine

behavior

behavior modification

behavior, combative

behavioral disorder

Behcet's syndrome

benign essential tremor

benign senescent forgetfulness

benzodiazepine

beta adrenergic blocker

blood dyscrasias, neurologic findings with

brain transplantation

cardiac arrest and resuscitation

cardiomyopathy

caregiver

carotid artery stenosis

CAT scan

CAT scan, abnormal

CAT scan, delta sign, empty

CAT scan, dementia

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, indications for

CAT scan, normal ventricular size with aging

CAT scan, venography

cataplexy

cavum septi pellucidi

cell fusion test

central core disease

central nervous system, infection of

central pontine myelinolysis

cerebellar plaques, amyloid

cerebral blood flow

cerebral cortical atrophy

cerebral death

cerebral dominance

cerebral edema

cerebral edema, vasogenic

cerebral embolism

cerebral glucose metabolism

cerebral hemisphere left-right asymmetry

cerebral infarction

cerebral ischemia

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, enzymes in

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, hydroxyindoleacetic acid, 5(5-HIAA)

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, serotonin

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, cost of

cerebrovascular accident, familial occurrence

cerebrovascular accident, infancy and childhood

cerebrovascular accident, multiple

cerebrovascular accident, prevention of

cerebrovascular accident, recurrent

cerebrovascular accident, silent

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, risk factors in

cerebrovascular disease, treatment of

Charcot-Marie-Tooth

Charles Bonnet's syndrome

chelation therapy

chemonecrosis

chemotherapy, CNS treatment and complications with

children

chloroquine

cholesterol

choline acetyltransferase

chromosomal abnormality

chronic fatigue syndrome

cigarette smoking

cinnarizine

cisternogram, radionuclide

citalopram

claustrophobia

clindamycin

Clinical Pathologic Conference(C.P.C.)

color vision, impaired

color vision, impaired, cerebral

comorbidities

competency

complications

comprehension, impaired

compulsivity

conflict of interest

confusion

congenital malformation

congenital malformation, non CNS

contraindications

controversies in neurology

corpus callosum

corpus callosum, atrophy of

corpus callosum, neoplasm of

cortical blindness

cortical-basal ganglionic degeneration

corticotropin-releasing factor

craniectomy, decompressive

crying, pathologic

cultured skin fibroblasts

degenerative diseases of CNS

dementia, age at onset

dementia, cerebrovascular disease causing

dementia, clinical diagnosis

dementia, diagnostic classification

dementia, diagnostic evaluation of

dementia, differential diagnosis of

dementia, driving with

dementia, early detection

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, incidence

dementia, mixed

dementia, posttraumatic

dementia, preexisting in stroke patient

dementia, presenile

dementia, prevalence of

dementia, prevention of

dementia, rapidly progressive

dementia, reversible

dementia, screening for

dementia, transmissible

dementia, treatment of

dementia, unknown etiology

denial of illness

deprenyl

depression

depth perception, impaired

developmental milestones, loss of

differential diagnosis

dihydroepiandosterone

dimebon

dipyridamole

disability rating scale, neurological

disability, neurological

disease modifying agents

disseminated intravascular coagulation(DIC)

dopamine beta hydroxylase

drug induced neurologic disorders

drug interactions

drug withdrawal

dural sinus thrombosis

dysexecutive syndrome

dyskinesia, buccal lingual facial

dystonia, drug induced

dystonic reaction, acute

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, focal delta activity

electroencephalogram, periodic complexes

electroencephalogram, spike activity

electromagnetic fields

electron microscopy

electronic monitoring

encephalitis, autoimmune

encephalitis, viral

encephalopathy

encephalopathy, anoxic

encephalopathy, Hashimoto's

encephalopathy, metabolic

endocarditis, native-valve

enzyme, muscle disease

epidemiology of neurology

epsilon-aminocaproic acid(E.A.C.A.)

ethics in neurology

evidence-based research

evoked potentials

excitotoxin

executive dysfunction

exercise

expert witness, medical

eye movement, disorders of

Fazio-Londe's disease

fever

fibrinolytic agents

fibrinolytic agents, intra-venous local infusion

fibrinolytic agents, utilization

football neurologic injuries

foreign accent syndrome

fracture, long bone

Friedreich's ataxia

frontal behavioral spatial syndrome

frontal lobe, anatomy and physiology

frontal lobe, behavior with disease of

frontal lobe, lesion of

frontal lobe, pathologic signs of

frontotemporal dementia, behavioral variant

fungal infection, CNS

gastrostomy, percutaneous endoscopic

gaze palsy

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

Gerstmann syndrome

Gerstmann-Straussler-Scheinker disease

Gilles de la Tourette syndrome

glioblastoma multiforme(astrocytoma Gr.III)

glioma

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

glutamic acid

GPS tracking

granulovacuolar degeneration

grasping

gray matter

Hallervorden Spatz disease

hallucination

hallucination, auditory

hallucination, visual

hallucination, visual, benign

haloperidol

handedness

head injury

head injury, hydrocephalus following

head injury, pediatric

heavy metal intoxication

hemianopia

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hemoglobin abnormality, neurologic complications of

hemorrhagic diathesis

hemosiderosis of CNS, superficial

hemosiderosis, subarachnoid

hepatic failure

hepatitis

hepatosplenomegaly

heralding manifestation

herbs

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes simplex virus

herpes virus infection

histamine-2 receptor blockers

histochemistry

HMGcoA reductase inhibitors

human immunodeficiency virus type 1

hydrocephalus, normal pressure

hyperpyrexia, CNS disorder causing

hyperreflexia

hypertension

hypertension, cerebrovascular disease with

hypotension, systemic

hypoxia

hypoxic encephalopathy

iatrogenic neurologic disorders

imbalance, postural

immunization, neurologic complications with

immunoperoxidase staining

immunosuppression

inappropriate behavior

inattention

incidence

inclusion bodies

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intracytopasmic

inclusion bodies, intranuclear

inclusion bodies, location of

incoordination

indomethacin

industrial neurologic disorders

infantile hemiplegia

infection

inflexibility, mental

intellectual deterioration

interferon

interobserver agreement

intracerebral hemorrhage

intracerebral hemorrhage, small

intracranial hypertension, benign

intracranial pressure, increased

intranasal medication

Jakob-Creutzfeldt disease

Jakob-Creutzfeldt disease, medical precaution with

jaundice

judgement, impaired

Kluver-Bucy syndrome

Kugelberg-Welander syndrome

laboratory values, normal

lacunar infarction

lacunar state

language disorder in adults

L-dopa

L-dopa, drug interactions with and side effects of

lead poisoning

lecanemab

lecithin

left-right orientation

leukemia, neurologic findings assoc.with

leuko-araiosis

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

life expectancy

life support, withdrawal of

lifestyle

limbic encephalitis

limbic system

limbic-predominant age-related TDP-43 encephalopathy

line bisection task

lipid lowering agent

lipid storage disorder of CNS

liver function enzymes

liver transplantation

lobar atrophy

locus ceruleus, lesion of

lymphoma involving CNS

machine learning

managed care

manganese intoxication

manic-depressive

marital status

medical-legal aspects of neurology

medication withdrawal

memantine

memory

memory enhancement

Memory Impairment Screen

memory, defect of recent

memory, disorder, treatment of

memory, evaluation of

memory, impairment of

memory, impairment of, isolated

memory, impairment of, subjective

mental status, abnormal

mental status, evaluation of

mesial temporal lobe

metrifonate

microhemorrhage, intracerebral

microtubule

middle cerebral artery territory infarction

middle cerebral artery, occlusion of

migraine

mild cognitive impairment

mild cognitive impairment converting to Alzheimer's disease

mimics

Mini Mental Status Examination

misdiagnosis

misdirection

misidentification

mitochondrial disease

molecular genetics

mongolism

monoamine oxidase inhibitors

monoclonal antibodies

movement disorder, drug induced

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, disappearing lesion on

MRI, false negative

MRI, field strength, high

MRI, voxel-based morphometry

MRS

multiple sclerosis

multiple sclerosis, diagnosis of

multiple system atrophy

muscle weakness, causes of

muscular dystrophy

muscular dystrophy, Duchenne

mutism

myasthenia gravis

myeloproliferative disorder

myopathy, drug-induced

myopathy, hypokalemic

myopathy, proximal

myopathy, steroid induced

neoplasm, intracranial

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve growth factor

neurofibrillary degeneration

neurofibrillary degeneration, causes of

neurofibromatosis 1

neurofibromatosis 2

neurofilament light chain protein

neuroleptic

neuroleptic, atypical

neurologic complications of, systemic disease

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic evaluation

neurologic examination

neurologic examination, focal

neuron specific enolase

neuronal ceroid-lipofuscinosis

neuronal degeneration

neuronal loss

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, amyloid

neuroprotective agents

non-dominant hemisphere

nonsteroidal anti-inflammatory drug

nucleus basalis of Meynert

nursing home

nylidrin

obsessive-compulsive disorder

occupational neurologic disorders

olanzapine

old age, driving and

old age, neurology of

olfactory bulb

opportunistic infection

opportunistic infection, CNS

optic atrophy

optic nerve, lesion of

optic neuropathy

oral contraceptives

oral contraceptives, cerbrovascular disease and

oral contraceptives, neurologic complications with

organ transplantation

orthostatic hypotension

osteoporosis

pain, abdominal

pain, increased response

parietal lobe, atrophy

parietal lobe, lesion of

parietal lobe, syndromes of

Parkinson disease

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, drug induced

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, heterogeneity of

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, postencephalitic

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

paroxysmal nocturnal hemoglobinuria

PAS positive material in the brain

pathologic reflex

pathology

patient information and support

peduncular hallucinosis

peptides, brain

perhexiline maleate

perihippocampal fissure

perimetry

perimetry, computerized

persistent vegetative state

persistent vegetative state, children

persistent vegetative state, etiology of

Pittsburgh Compound B

placebo

plasminogen deficiency

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

pneumoencephalogram(PEG)

pneumonia

poison, mercury

poison, neurologic problems with

polycythemia, primary

polyneuropathy

polysomnogram

posterior cerebral artery occlusion

posterior cortical atrophy

posterior leukoencephalopathy syndrome

postural abnormality

potassium channel antibodies

practice guidelines

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

primary thrombocythemia

prion disease

progesterone

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive supranuclear palsy

protein 14-3-3, cerebrospinal fluid

protein 14-3-3, cerebrospinal fluid, false positive

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

pupil, abnormality in neurologic disorders

radiation therapy, CNS treatment and complications with

radiotracer imaging

rapidly progressing neurologic illness

reading

reading disorder, acquired

reading problem, causes of

recombinant DNA

recurrent

Red flags

reduplicative paramnesia

release phenomena

REM sleep

remote effect of cancer on the nervous system

remternetug

repetitive questioning

research

retinal degeneration

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

rheumatoid arthritis, neurologic complications of

rhinorrhea, CSF

rigidity

risk factors

risk factors, modification

risk-benefit assessment

salivation, excessive

seizure, diagnosis of

seizure, psychomotor-temporal lobe

seizure, risk factors for

seizure, surgical treatment of

selective serotonin reuptake inhibitors

serologic testing of cerebrospinal fluid

serotonin

sertraline

serum alanine aminotransferase

sexual behavior, disorder of

shadowing

shared decision making

single photon emission computed tomography

single photon emission computed tomography, false negative

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

sleep

sleep pathology and physiology

slow virus infection of CNS

smell

Smell Identification Test

snout reflex

sodium-glucoe cotransporter-2 inhibitors

speech disorder

speech, loss of

spinal cord, injury of

spinal muscular atrophy

spinocerebellar ataxia

spinocerebellar ataxia type 1

splenomegaly

spongy degeneration of brain

sports medicine, neurology of

staining reactions in neuropathology

statin therapy

stem cell transplantation

stereotyped behavior

steroid

steroid therapy, CNS treatment and complications with

stimulant drugs

stimulation, deep brain

stooped posture

straight sinus

stress, emotional

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subacute sclerosing panencephalitis, adult onset

subarachnoid hemorrhage

superior sagittal sinus thrombosis

symmetric brain lesions

systemic exertion intolerance disease

temporal lobe, atrophy

temporal lobe, lesion

temporal lobe, lesion, bilateral

tetrahydroaminoacridine

thrombocytopenia

thrombophlebitis

thyroiditis

tissue plasminogen activator, intravenous

toxic encephalopathy

toxoplasmosis, CNS

TRAILBLAZER-ALZ trial

transient ischemic attack

transient ischemic attack, treatment of

trauma

trazodone

treatment of neurologic disorder

treatment, non-pharmacologic

trinucleotide repeats

vaccination, neurologic complications with

vasodilating agents in treatment of cerebrovascular disease

velnacrine

ventricular enlargement

vincamine

vincristine neurotoxicity

vinpocetine

viral infection

viral infection, CNS

visual acuity, decreased

visual evoked response

visual field defect

visual field testing

visual fields

visual fields, constricted

visuospatial disturbance

vitamin E

vitamin supplementation

vitamin therapy

walking, difficulty with

Werdnig-Hoffman disease

white matter disease, periventricular

whites

Williams syndrome

word-finding difficulty

workup

writing

Showing articles 150 to 200 of 760 << Previous Next >>

Medical Decision-Making Capacity in Mild Cognitive Impairment: A 3-Year Longitudinal Study
Neurol 71:1474-1480, Okonkwo,O.C.,et al, 2008

Prodromal Alzheimers Disease: Successive Emergence of the Clinical Symptoms
Ann Neurol 64:492-498,479, Amieva,H.,et al, 2008

Memory Problems in an Older Person
BMJ 337:1235-1236, Suresh,K.,et al, 2008

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008

Driving and Dementia
BMJ 334:1365-1369, Breen,D.A.,et al, 2007

The Neuroprotective Effects of Caffeine: A Prospective Population Study (the Three City Study)
Neurol 69:536-545, Ritchie,K.,et al, 2007

Donepezil Preserves Cognition and Global Function in Patients With Severe Alzheimer Disease
Neurol 69:459-469, Black,S.E.,et al, 2007

A Review of Screening Tests for Cognitive Impairment
JNNP 78:790-799, Cullen,B.,et al, 2007

Relation Between Smoking and Risk of Dementia and Alzheimer Disease: The Rotterdam Study
Neurol 69:998-1005, Reitz,C.,et al, 2007

Incident Dementia in Women is Preceded by Weight Loss by a Least a Decade
Neurol 69:739-746, Knopman,D.S.,et al, 2007

Donepezil for the Treatment of Agitation in Alzheimers Disease
NEJM 357:1382-1392,1441, Howard,R.J.,et al, 2007

Variability of Age at Onset in Siblings With Familial Alzheimer Disease
Arch Neurol 64:1743-1748, G�mez-Tortosa,E.,et al, 2007

Hypertension and the Risk of Mild Cognitive Impairment
Arch Neurol 64:1734-1740, Reitz,C.,et al, 2007

Disease-Modifying Therapies for Alzheimer Disease: Challenges to Early Intervention
Neurol 69:1622-1634, Cummings,J.L.,et al, 2007

Dementia Screening in Primary Care: Is It Time?
JAMA 298:2409-2411, Brayne,C.,et al, 2007

The Woman Who Needed a Pet
Surv Ophthalmol 51:592-595, Atchison,M.,et al, 2006

Coxibs and Alzheimers Disease: Should They Stay or Should They Go?
Ann Neurol 59:219-228, Firuzi,O. &Pratico,D., 2006

Mild Cognitive Impariment is Early-Stage Alzheimer Disease
Arch Neurol 63:15-16, Morris,J.C., 2006

A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease
Arch Neurol 63:49-54, Reisberg,B.,et al, 2006

Effect of Enhanced Psychosocial Care on Antipsychotic Use in Nursing Home Residents with Severe Dementia; Cluster Randomised Trial
BMJ 332:756-758,741, Fossey,J.,et al, 2006

Donepezil in Patients with Severe Alzheimers Disease: Double-Blind, Parallel-Group, Placebo-Controlled Study
Lancet 367:1057-1065,1031, Winblad,B.,et al, 2006

Mild Cognitive Impairment
Lancet 367:1262-1270, Gauthier,S.,et al, 2006

Neuropathologic Features of Amnestic Mild Cognitive Impairment
Arch Neurol 63:665-672,645, Petersen,R.C.,et al, 2006

Frontotemporal Dementia: Clinicopathological Correlations
Ann Neurol 59:952-962, Forman,M.S.,et al, 2006

Behavioral Effects of Memantine in Alzheimer Disease Patients Receiving Donepezil Treatment
Neurol 67:57-63, Cummings,J.L.,et al, 2006

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimers Disease
NEJM 355:1525-1538,1604, Schneider,L.S.,et al, 2006

PET of Brain Amyloid and Tau in Mild Cognitive Impairment
NEJM 355:2652-2663, Small,G.W.,et al, 2006

A-beta Vaccination Effects on Plaque Pathology in the Absence of Encephalitis in Alzheimer Disease
Neurol 64:129-131,10, Masliah,E.,et al, 2005

Bone Mineral Density and the Risk of Alzheimer Disease
Arch Neurol 62:107-111, Tan,Z.S.,et al, 2005

A 32-Year Prospective Study of Change in Body Weight and Incident Dementia
Arch Neurol 62:55-60,20, Stewart,R.,et al, 2005

Genetic Factors in Alzheimer's Disease
NEJM 352: 862-863, 884, Bird, T., 2005

Unawareness of Cognitive Deficit (Cognitive Anosognosia) in Probable AD and Control Subjects
Neurol 64:693-699, Barrett, A.M., et al, 2005

Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005

Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy
Arch Neurol 62:721-728, Mega,M.S.,et al, 2005

Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease
Arch Neurol 62:753-757, Sparks,D.L.,et al, 2005

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
NEJM 352:2379-2388,2439, Petersen,R.C.,et al, 2005

Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005

A 10-Item Smell Identification Scale Related to Risk for Alzheimers Disease
Ann Neurol 58:155-160, Taberr,M.H.,et al, 2005

Cholinesterase Inhibitors for Patients with Alzheimers Disease: Systematic Review of Randomised Clinical Trials
BMJ 331:321-323, Kaduszkiewicz,H.,et al, 2005

Protein S Deficiency in HIV Associated Ischaemic Stroke:An Epiphenomenon of HIV Infection
JNNP 76:1455-1456,1331, Mochan,A.,et al, 2005

Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia, Meta-analysis of Randomized Placebo-Controlled Trials
JAMA 294:1934-1943,1963, Schneider,L.S.,et al, 2005

Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease
JNNP 76:1624-1629, Masse,I.,et al, 2005

Global Prevalence of Dementia: A Delphi Consensus Study
Lancet 366:2112-2117, Ferri,C.P.,et al, 2005

Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements
Arch Neurol 61:82-88, Zandi,P.P.,et al, 2004

Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004

Imaging Cerebral Atrophy:Normal Ageing to Alzheimer's Disease
Lancet 363:392-394, Fox,N.C.&Schott,J.M., 2004

Comparison of Different MRI Brain Atrophy Rate Measures with Clinical Disease Progression in AD
Neurol 62:591-600, Jack, Jr.,C.R.,et al, 2004

Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Arch Neurol 61:661-666, Arvanitakis,Z.,et al, 2004

Size of the Treatment Effect on Cognition of Cholinesterase Inhibition in Alzheimer's Disease
JNNP 75:677-685, Rockwood,K., 2004

Estimating Prognosis for Nursing Home Residents with Advanced Dementia
JAMA 291:2734-2740, Mitchell,S.L.,et al, 2004

Showing articles 150 to 200 of 760 << Previous Next >>